Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAZ320 in Type 2 Diabetes
NCT02060916Phase 2Completed
- Sponsor
- Boston Therapeutics, Inc.
- Start
- Mar 2011
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of BTI320 in type 2 diabetes mellitus (T2DM), sponsored by Boston Therapeutics, Inc.. Started Mar 2011; status: completed.
02
Drugs
BTI320
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02060916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02060916.